January 2021 Issue Table Of Contents
Source: Life Science Leader

From The Editor
Feature Articles
- Frank Gupton – Revolutionizing Pharma Manufacturing From The Outside In
- How A First-Time Pharma CEO Faces Hypergrowth
Capitol Perspectives
CEO Corner
Companies To Watch
From Policy to Execution
Industry Research
Inside The Industry
- Going Public In Mid-Pandemic
- 5 Elements Of A Long-Term Partnership Strategy
- China’s Proposed IP Law Changes May Drive Pharma Innovation
- Transforming Your Organizational Mindset On Quality Compliance
- Increasing Patient Diversity In Clinical Trials
- Emerging Trends For Life Sciences IPOs During The Pandemic
Industry Leader
Leadership Lessons
Ask The Board
- Could The Pandemic Be Just What The Doctor Ordered For Bringing More R&D Minds To Major Biopharma Hubs (e.g., Boston, San Fran)?
- What COVID-19-Induced Trends Impacting Your Company’s Operations Do You Anticipate Continuing Well Beyond The End Of The Current Pandemic?
- What Happens If We Have A Bunch Of COVID-19 Therapeutic And Vaccine Development Failures? Could Biopharma Be The Next Dot-Com Bubble To Burst In 2021?
Life Science Leader
This website uses cookies to ensure you get the best experience on our website. Learn more